Novel Treatment for Rare Pediatric Genetic Disorder
Applied current paradigms of Medicaid and commercial insurer coverage, coding, and payment to a treatment under development for a severe rare pediatric genetic condition.
Applied current paradigms of Medicaid and commercial insurer coverage, coding, and payment to a treatment under development for a severe rare pediatric genetic condition.
CEO insights
Related articles
Real analysis from people who’ve been there
Evaluation of Biosimilar Utilization by Hospital Types
Worked with a pharmaceutical trade organization to identify biosimilars of interest.
Advocacy Coalition for Uptake of Comprehensive Genomic Profiling
Worked with a diverse group of industry stakeholders including diagnostics manufacturers, laboratories, academic institutions, and disease-specific advocacy groups to redefine comprehensive genomic profiling through the creation of a “new narrative”.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.